Table 1.
Clinical characteristics, and results of 30 days stable state monitoring in 31 patients with COPD.
| Mean | SD | |
|---|---|---|
| Age (years) | 72.1 | 6.9 |
| FEV1 (l)* | 1.10 | 0.49 |
| FEV1 (% predicted)* | 45.9 | 22.7 |
| FVC (l)* | 2.46 | 0.82 |
| FEV1/FVC* | 0.45 | 0.15 |
| Body Mass Index (BMI) (kgm-2) | 27.0 | 5.6 |
| St. George's Respiratory Questionnaire (SGRQ) (Total Score) | 49.9 | 16.0 |
| Median | IQR | |
| Smoking (Pack years) | 51 | 38-66 |
| Exacerbation Frequency** | 3 | 1-4 |
| n | % | |
| Male | 21 | 68 |
| Current Smokers | 6 | 19 |
| β-blocker or rate-limiting Calcium-channel antagonist | 7 | 23 |
| Mean | ||
| Stable Mean Heart Rate (min-1) | 77.8 | |
| Stable SD Heart Rate (min-1) | 4.9 | |
| Stable Mean Oxygen Saturation (SpO2) (%) | 94.8 | |
| Stable SD Oxygen Saturation (SpO2) (%) | 1.0 | |
| Stable Mean Peak Expiratory Flow (PEF) (lmin1) | 231.5 | |
| Stable SD Peak Expiratory Flow (PEF) (lmin1) | 11.4 | |
*: post-bronchodilator.
**: the number of symptom-defined exacerbations over the previous year of the study.